Abstract
Introduction: Cerebral vascular disease (CVD) affects approximately 12.2 million people per year, it is the third leading cause of death and disability combined worldwide. In Mexico there was no organized stroke care network within the public health system, in order to offer different reperfusion therapies in 2019 we integrated the first network in the Mexican public health system called ResISSSTE Cerebro. Cases Reports: Case 1 - 95-year-old woman with acute cerebral infarction, arrived 2.5 hours after the onset of symptoms at an essential center (EC) of the network, was transferred at 5.5 hours to the AC at a distance of 3.3 km, the NIHSS (National Institutes of Health Stroke Severity Scale) at admission was 21 points, mechanical thrombectomy (MT) with Rankin 1 was performed at discharge and at 90 days. Case 2 - 95-year-old woman with acute cerebral infarction, arrived 60 minutes later at a network CE, moved to the AC at a distance of 103 km at 4.3 hours with 10-point NIHSS, TIV and TM were performed with NIHSS post-treatment of 1 point and Rankin 1 at 30 and 360 days. Conclussion: In low-middle income countries (LMIC) there are many barriers to stroke care, so organized stroke care networks must be built that allow access to basic and advanced imaging studies that are necessary for the evaluation of patients. requiring cerebral reperfusion therapy, without excluding patients over 80 years of age.
References
Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, et al. Ischaemic stroke. Nat Rev Dis Primers [Internet]. Diciembre de 2019 [citado 12 de mayo de 2022];5(1):70. Disponible en: http://www.nature.com/articles/s41572-019-0118-8
INEGI, «Características de las defunciones registrada en México durante 2020,» Comunicado de Prensa. 2021; 592:27-28. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2021/EstSociodemo/DefuncionesRegistradas2020preliminar.pdf
Luengo-Fernandez R, Paul NLM, Gray AM, Pendlebury ST, Bull LM, Welch SJV, et al. Population-Based Study of Disability and Institutionalization After Transient Ischemic Attack and Stroke: 10-Year Results of the Oxford Vascular Study. Stroke [Internet]. Octubre de 2013 [citado 12 de mayo de 2022];44(10):2854-61. Disponible en: https://www.ahajournals.org/doi/10.1161/STROKEAHA.113.001584
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. The Lancet [Internet]. Noviembre de 2014 [citado 12 de mayo de 2022];384(9958):1929-35. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0140673614605845
Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, et al. Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA [Internet]. 3 de noviembre de 2015 [citado 12 de mayo de 2022];314(17):1832. Disponible en: http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.2015.13767
Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. The Lancet [Internet]. Abril de 2016 [citado 12 de mayo de 2022];387(10029):1723-31. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S014067361600163X
Hankey GJ. Stroke. The Lancet [Internet]. Febrero de 2017 [citado 12 de mayo de 2022];389(10069):641-54. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S014067361630962X
Hankey GJ, Blacker DJ. Is it a stroke? BMJ [Internet]. 15 de enero de 2015 [citado 19 de abril de 2022];350(jan15 1):h56-h56. Disponible en: https://www.bmj.com/lookup/doi/10.1136/bmj.h56
Owolabi MO, Thrift AG, Mahal A, Ishida M, Martins S, Johnson WD, et al. Primary stroke prevention worldwide: translating evidence into action. The Lancet Public Health [Internet]. Enero de 2022 [citado 12 de mayo de 2022];7(1):e74-85. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S2468266721002309
Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. The Lancet [Internet]. Junio de 2012 [citado 16 de mayo de 2022];379(9834):2364-72. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0140673612607387
Valle J, Lopera E, Guillán M, Muñoz M, Sánchez A, Hernández Y. Imitadores del ictus: un reto para el médico de urgencias. An Sist Sanit Navar. 2014;37:12. https://dx.doi.org/10.4321/S1137-66272014000100013
Gobierno de México. Enfermedad Vascular Cerebral (EVC), entre las primeras causas de muerte. Octubre 2019. No.455/2019/IMSS/SALUD/ISSSTE. Disponible en: http://www.imss.gob.mx/prensa/archivo/201910/455
Berge E, Whiteley W, Audebert H, De Marchis G, Fonseca AC, Padiglioni C, et al. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. European Stroke Journal [Internet]. Marzo de 2021 [citado 19 de abril de 2022];6(1):I-LXII. Disponible en: http://journals.sagepub.com/doi/10.1177/2396987321989865
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke [Internet]. Diciembre de 2019 [citado 19 de abril de 2022];50(12). Disponible en: https://www.ahajournals.org/doi/10.1161/STR.0000000000000211
Bush CK, Kurimella D, Cross LJS, Conner KR, Martin-Schild S, He J, et al. Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. Toyoda K, editor. PLoS ONE [Internet]. 25 de enero de 2016 [citado 20 de abril de 2022];11(1):e0147287. Disponible en: https://dx.plos.org/10.1371/journal.pone.0147287
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Revista de Medicina Clínica